Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cabot (CBT) Shares Outstanding (Weighted Average) (2016 - 2025)

Cabot (CBT) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $52.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 4.53% to $52.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.7 million through Dec 2025, down 4.53% year-over-year, with the annual reading at $53.7 million for FY2025, 4.11% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $52.7 million at Cabot, down from $53.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $57.7 million in Q4 2021, with the low at $52.7 million in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $55.8 million, with a median of $56.1 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) rose 0.87% in 2021, then dropped 4.53% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $57.7 million in 2021, then fell by 2.43% to $56.3 million in 2022, then dropped by 1.78% to $55.3 million in 2023, then fell by 0.18% to $55.2 million in 2024, then dropped by 4.53% to $52.7 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $52.7 million, $53.7 million, and $53.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.